You're reading the free version. Trader adds the live tape and alerts.
Start tracking
UTHR Exercise Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Oct 19, 2026
Exercise
Calculated transaction value
$0
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Oct 16, 2026
Public filing date
Oct 19, 2026
Filing lag
Filed 3 days later
UTHR daily price context
Close on/before transaction
$533.12
Oct 16, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option on Common Stock
- Quantity / price
- 9,500 shares @ $0
- SEC ownership
- Indirect
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001106578-26-000166
Filing cohort
Transactions in this filing
Showing 15 of 15
Trades
15
Issuers
1
Estimated value
$6.2M
Buys / sales
0 / 13
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Sale | Oct 16, 2026 | $342.02K |
| United Therapeutics Corp UTHR Current | Exercise | Oct 16, 2026 | $0 |
| United Therapeutics Corp UTHR | Sale | Oct 16, 2026 | $286.58K |
| United Therapeutics Corp UTHR | Sale | Oct 16, 2026 | $408.68K |
| United Therapeutics Corp UTHR | Sale | Oct 16, 2026 | $215.96K |
| United Therapeutics Corp UTHR | Sale | Oct 16, 2026 | $91.53K |
| United Therapeutics Corp UTHR | Sale | Oct 16, 2026 | $464.21K |
| United Therapeutics Corp UTHR | Exercise | Oct 16, 2026 | $1.12M |
| United Therapeutics Corp UTHR | Sale | Oct 16, 2026 | $127.31K |
| United Therapeutics Corp UTHR | Sale | Oct 16, 2026 | $544.3K |
| United Therapeutics Corp UTHR | Sale | Oct 16, 2026 | $1.27M |
| United Therapeutics Corp UTHR | Sale | Oct 16, 2026 | $969.58K |
| United Therapeutics Corp UTHR | Sale | Oct 16, 2026 | $212.19K |
| United Therapeutics Corp UTHR | Sale | Oct 16, 2026 | $21.75K |
| United Therapeutics Corp UTHR | Sale | Oct 16, 2026 | $128.96K |